Total Assets
Breakdown
| Segment | Q2 '21 | Q2 '22 | Q2 '23 | Q2 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Medical Surgical | $39.32B | $36.94B | $36.25B | $33.59B | $33.32B | $33.33B | $32.98B | $32.75B |
| Neuroscience | $17.15B | $16.92B | $18.35B | $18.27B | $18.48B | $18.43B | $18.48B | $18.45B |
| Cardiovascular | $15.03B | $14.49B | $16.05B | $16.13B | $16.55B | $16.57B | $16.66B | $16.75B |
| Diabetes Group | $3.67B | $3.80B | $3.93B | $4.00B | $4.14B | $4.21B | $4.27B | $4.31B |
| Other operating segment | — | — | — | $547.00M | $296.00M | $202.00M | $216.00M | $207.00M |
| Total | $93.08B | $90.98B | $90.95B | $89.98B | $91.68B | $90.97B | $91.35B | $91.49B |
Segments
NeuroscienceView metric
Medical SurgicalView metric
Other operating segmentView metric
CardiovascularView metric
Diabetes GroupView metric